Selected article for: "early detection and monitoring early detection"

Author: Sivandzadeh, Gholam Reza; Askari, Hassan; Safarpour, Ali Reza; Ejtehadi, Fardad; Raeis-Abdollahi, Ehsan; Vaez Lari, Armaghan; Abazari, Mohammad Foad; Tarkesh, Firoozeh; Bagheri Lankarani, Kamran
Title: COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges
  • Cord-id: abc34vps
  • Document date: 2021_8_6
  • ID: abc34vps
    Snippet: It is hypothesized that liver impairment caused by coronavirus disease 2019 (COVID-19) infection might play a central role in severe clinical presentations. Liver injury is closely associated with severe disease and, even with antiviral drugs, have a poor prognosis in COVID-19 patients. In addition to the common hepatobiliary disorders caused by COVID-19, patients with pre-existing liver diseases demand special considerations during the current pandemic. Thus, it is vital that upon clinical pres
    Document: It is hypothesized that liver impairment caused by coronavirus disease 2019 (COVID-19) infection might play a central role in severe clinical presentations. Liver injury is closely associated with severe disease and, even with antiviral drugs, have a poor prognosis in COVID-19 patients. In addition to the common hepatobiliary disorders caused by COVID-19, patients with pre-existing liver diseases demand special considerations during the current pandemic. Thus, it is vital that upon clinical presentation, patients with concurrent pre-existing liver disease associated with metabolic dysfunction and COVID-19 be managed properly to prevent liver failure. Careful monitoring and early detection of liver damage through biomarkers after hospitalization for COVID-19 is underscored in all cases, particularly in those with pre-existing metabolic liver injury. The purpose of this study was to determine most recent evidence regarding causality, potential risk factors, and challenges, therapeutic options, and management of COVID-19 infection in vulnerable patients with pre-existing liver injury. This review aims to highlight the current frontier of COVID-19 infection and liver injury and the direction of liver injury in these patients.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • abdominal pain and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71
    • abdominal pain and acute liver: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • abdominal pain and acute liver failure: 1, 2, 3, 4
    • abdominal pain and acute liver injury: 1, 2, 3, 4, 5
    • abdominal pain and acute phase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • abdominal pain and acute phase protein: 1
    • abdominal pain and additional research: 1, 2, 3
    • abdominal pain and additional risk: 1, 2, 3, 4
    • abdominal pain and liver biopsy: 1, 2, 3, 4
    • abdominal pain and liver cirrhosis: 1, 2, 3
    • abdominal pain and liver damage: 1, 2, 3, 4, 5, 6, 7, 8
    • abdominal pain and liver disease patient: 1
    • abdominal pain and liver duct: 1, 2
    • abdominal pain and liver dysfunction: 1, 2, 3, 4
    • abdominal pain and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8
    • abdominal pain and liver enzyme elevation: 1
    • abdominal pain and liver failure: 1, 2, 3, 4, 5, 6, 7, 8
    • abdominal pain and liver failure onset: 1